Pages that link to "Q34697293"
Jump to navigation
Jump to search
The following pages link to PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection (Q34697293):
Displaying 50 items.
- Role of the PD-1 pathway in the immune response (Q26828748) (← links)
- Transplantation tolerance and its outcome during infections and inflammation (Q26829817) (← links)
- Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells (Q26851647) (← links)
- The CD8 T-cell response during tolerance induction in liver transplantation (Q28079184) (← links)
- Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model (Q33767212) (← links)
- PD-1 regulates T cell proliferation in a tissue and subset-specific manner during normal mouse pregnancy (Q33893319) (← links)
- Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice. (Q33967995) (← links)
- Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury (Q34164098) (← links)
- LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L (Q34172252) (← links)
- Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. (Q34193534) (← links)
- Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway (Q34593527) (← links)
- PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue (Q34597955) (← links)
- The programmed death (PD)-1/PD-ligand 1 pathway regulates graft-versus-host-reactive CD8 T cells after liver transplantation (Q34598808) (← links)
- Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patients (Q34639457) (← links)
- The role of programmed cell death ligand-1 (PD-L1/CD274) in the development of graft versus host disease (Q34673038) (← links)
- TIM4 Regulates the Anti-Islet Th2 Alloimmune Response (Q34791435) (← links)
- The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo (Q35118927) (← links)
- Cardiac allograft vasculopathy: a donor or recipient induced pathology? (Q35244151) (← links)
- The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance. (Q35403407) (← links)
- Influence of Interferon-γ Deficiency in Immune Tolerance Induced by Male Islet Transplantation (Q35745499) (← links)
- Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants. (Q35776458) (← links)
- Increased circulating follicular helper T cells with decreased programmed death-1 in chronic renal allograft rejection. (Q35829453) (← links)
- CD28 family and chronic rejection: "to belatacept...And beyond!". (Q36037639) (← links)
- The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model (Q36303692) (← links)
- Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation (Q36327666) (← links)
- Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types. (Q36939402) (← links)
- Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice (Q36983949) (← links)
- The PD-1/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats (Q36985976) (← links)
- Harnessing negative T-cell costimulatory pathways to promote engraftment (Q37030982) (← links)
- Immune Tolerance for Autoimmune Disease and Cell Transplantation (Q37099107) (← links)
- Divergent role of donor dendritic cells in rejection versus tolerance of allografts (Q37123243) (← links)
- PD-1/PD-L1 Interaction Maintains Allogeneic Immune Tolerance Induced by Administration of Ultraviolet B-Irradiated Immature Dendritic Cells (Q37172083) (← links)
- Expression and function of PDCD1 at the human maternal-fetal interface (Q37208445) (← links)
- PD-1/PD-L1, PD-1/PD-L2, and other co-inhibitory signaling pathways in transplantation. (Q37228818) (← links)
- Prevention of allograft rejection in heart transplantation through concurrent gene silencing of TLR and Kinase signaling pathways (Q37277855) (← links)
- Maternal PD-1 regulates accumulation of fetal antigen-specific CD8+ T cells in pregnancy (Q37393109) (← links)
- Programmed to direct alloimmunity (Q37765466) (← links)
- Bacterial infections, alloimmunity, and transplantation tolerance (Q37815276) (← links)
- T-cell co-stimulatory blockade in transplantation: two steps forward one step back! (Q38148197) (← links)
- Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus. (Q38339535) (← links)
- T Cell Cosignaling Molecules in Transplantation (Q38837473) (← links)
- Immune checkpoint inhibitors in challenging populations (Q38939708) (← links)
- Tracking of TCR-Transgenic T Cells Reveals That Multiple Mechanisms Maintain Cardiac Transplant Tolerance in Mice (Q39289936) (← links)
- Co-inhibitory molecules: Controlling the effectors or controlling the controllers? (Q39761212) (← links)
- Distinct strategies are required to suppress antigen-specific responses to genetically modified keratinocytes and fibroblasts (Q40309811) (← links)
- Erosion of Transplantation Tolerance After Infection (Q40641361) (← links)
- Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce Type 2 helper T cell (Th2) bias at the maternal-fetal interface (Q40891481) (← links)
- Development of a Modular Assay for Detailed Immunophenotyping of Peripheral Human Whole Blood Samples by Multicolor Flow Cytometry (Q40952760) (← links)
- Dickkopf-3, a tissue-derived modulator of local T-cell responses (Q41894585) (← links)
- Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report (Q42315438) (← links)